Advanced Biotherapy Inc (791833) SEC Filing 8-K Material Event for the period ending Sunday, November 30, 2008

Advanced Biotherapy Inc

CIK: 791833

View differences made from one to another to evaluate Advanced Biotherapy Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Biotherapy Inc.


Assess how Advanced Biotherapy Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Biotherapy Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2008 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 791833
Form Type: 8-K Corporate News
Accession Number: 0001144204-08-067762
Submitted to the SEC: Wed Dec 03 2008 5:13:52 PM EST
Accepted by the SEC: Wed Dec 03 2008
Period: Sunday, November 30, 2008
Industry: Commercial Physical And Biological Research
  1. Event for Officers
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: